Home › Drug Codes › J Codes › J7189 · NOVOSEVEN RT
Updated October 1st, 2026

NOVOSEVEN RT J Code: J7189

Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram

Login to unlock all benchmarks
Medicare Payment Limit ?
$2.774
/ HCPCS billing unit
APC Payment Limit ?
$2.774
/ HCPCS billing unit · APC 1705
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
4
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram
HCPCS Added Date January 1, 2006
Manufacturer Novo Nordisk
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Kit

About NOVOSEVEN RT

Novoseven RT is a medication aligned to the HCPCS J Code: J7189 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the intravenous route and manufactured by Novo Nordisk.

According to CMS Drug Use Information: This medication is used to treat and prevent bleeding in people with a certain condition (hemophilia type A or B). Some brands may also be used to treat and prevent bleeding in people with low levels of factor VII or Glanzmann's thrombasthenia. People with these conditions are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIIa, which is a protein (clotting factor) in the blood that works with other clotting factors to help the blood clot and stop bleeding.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00169-7201-01 Novoseven RT Novo Nordisk 1000 Kit
00169-7202-01 Novoseven RT Novo Nordisk 2000 Kit
00169-7205-01 Novoseven RT Novo Nordisk 5000 Kit
00169-7208-01 Novoseven RT Novo Nordisk 8000 Kit
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

NOVOSEVEN RT Pricing & Reimbursement

J7189 Private Payer Reimbursement
$2.48 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

NOVOSEVEN RT CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Novoseven RT (J7189) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

NOVOSEVEN RT Medically Unlikely Edits (MUE)

The most billing units of J7189 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mcg. The limit is different in the office and the hospital. Use the one for your setting.

Practitioner Office
13,000 units / day
= 13,000 mcg per day
Hospital Outpatient
26,000 units / day
= 26,000 mcg per day

MAI 1 · Line Edit. Per-line limit: units are checked per claim line; medically necessary units beyond the limit may be billable on separate lines with appropriate modifiers. See all MUE limits →

mcg Enter a dose to see how many billing units it is and whether it is under the limit.

NOVOSEVEN RT Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acquired hemophilia Congenital Factor VII deficiency Glanzmann's thrombasthenia Hemophilia A or B with inhibitors

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Novoseven Rt billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for NOVOSEVEN RT.
Are there any available Novoseven Rt patient assistance programs?
NOVOSEVEN RT patient assistance information can be found through Novo Nordisk. Visit Here →
Where can I find Novoseven Rt prescribing information?
NOVOSEVEN RT prescribing information can be found at the link below: Visit Here →
Where can I find Novoseven Rt side effect information?
Our team has not yet identified a source of side effects information for NOVOSEVEN RT. Please check back in a few weeks.
Does billing NOVOSEVEN RT require JZ/JW wastage modifiers?
CMS has identified NOVOSEVEN RT(J7189) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.